At any time during the joint clinical assessment, the JCA Subgroup may seek input on the disease and therapeutic area from patient organisations, healthcare professional organisations or clinical and learned societies via the members of the HTA stakeholder network.
Art. 8 Regulation (EU) 2024/1381
Consultation of stakeholder organisations during joint clinical assessments
In forcesince 23 May 2024